November 4, 2024 ACT 2024: Stay Ahead With Scantox’s Expanded Toxicology Services September 29, 2024 Scantox Showcases Cell and Gene Therapy Capabilities at ESGCT 2024 September 18, 2024 Discover Scantox’s Innovative Preclinical Model Systems at Neuroscience 2024 September 9, 2024 Scantox Group acquires Gentronix, a world leader in genetic toxicology August 22, 2024 Maximize Partnership Opportunities at Eurotox and NLS Days June 3, 2024 Finding Solutions for Neuroinflammation – Scantox at CNS Therapeutics Xchange 2024 May 14, 2024 Neuro4D: A Focused Meeting of Neuroscience Experts May 6, 2024 Minipigs in Focus: Join Scantox at the 16th MRF in Amsterdam April 24, 2024 Annual Report 2023 released April 2, 2024 Scantox closes the acquisition of QPS Neuropharmacology – now Scantox Neuro February 20, 2024 Visit Scantox at SOT in Salt Lake City: Discover Expanded Service Offerings and Collaborative Atmosphere November 30, 2023 Scantox acquires QPS Austria’s Neuropharmacology Division November 20, 2023 Scantox continues its growth journey with the acquisition of Solural Pharma November 8, 2023 Scantox appoints Morten Fjordholt as Sr. Business Development Director August 31, 2023 Scantox acquires Q&Q – strengthening its offering within bioanalytical services July 7, 2023 Scantox appoints Andy Brown as Group Chief Commercial Officer June 14, 2023 Exclusive genOway distributors in the Nordics April 26, 2023 Scantox Certified as 2023 Great Place to Work January 27, 2023 Scantox Wins ’Company of the Year 2022’ Award November 21, 2022 Danish Award Nomination October 6, 2022 Humanized Minipigs August 31, 2022 Scantox Acquires Timeline Bioresearch and Adlego Biomedical ACT 2024: Stay Ahead With Scantox’s Expanded Toxicology Services November 4, 2024 Scantox Showcases Cell and Gene Therapy Capabilities at ESGCT 2024 September 29, 2024 Discover Scantox’s Innovative Preclinical Model Systems at Neuroscience 2024 September 18, 2024 Scantox Group acquires Gentronix, a world leader in genetic toxicology September 9, 2024 Maximize Partnership Opportunities at Eurotox and NLS Days August 22, 2024 Finding Solutions for Neuroinflammation – Scantox at CNS Therapeutics Xchange 2024 June 3, 2024 Neuro4D: A Focused Meeting of Neuroscience Experts May 14, 2024 Minipigs in Focus: Join Scantox at the 16th MRF in Amsterdam May 6, 2024 Annual Report 2023 released April 24, 2024 Scantox closes the acquisition of QPS Neuropharmacology – now Scantox Neuro April 2, 2024 Visit Scantox at SOT in Salt Lake City: Discover Expanded Service Offerings and Collaborative Atmosphere February 20, 2024 Scantox acquires QPS Austria’s Neuropharmacology Division November 30, 2023 Scantox continues its growth journey with the acquisition of Solural Pharma November 20, 2023 Scantox appoints Morten Fjordholt as Sr. Business Development Director November 8, 2023 Scantox acquires Q&Q – strengthening its offering within bioanalytical services August 31, 2023 Scantox appoints Andy Brown as Group Chief Commercial Officer July 7, 2023 Exclusive genOway distributors in the Nordics June 14, 2023 Scantox Certified as 2023 Great Place to Work April 26, 2023 Scantox Wins ’Company of the Year 2022’ Award January 27, 2023 Danish Award Nomination November 21, 2022 Humanized Minipigs October 6, 2022 Scantox Acquires Timeline Bioresearch and Adlego Biomedical August 31, 2022
Visit Scantox at SOT in Salt Lake City: Discover Expanded Service Offerings and Collaborative Atmosphere February 20, 2024
